This binds to target mRNAs including tumor necrosis factor-α (TNF-α) [28], C-reactive protein and interleukin-1 receptor-associated kinase-1 (IRAK1) [29], which affect vascular damage responses and inflammation-related atherosclerosis in the development of stroke. Here, IRAK1 is linked to stroke disorder.